iGii Revolutionizes Nanomaterial Production with £8.8M Funding Boost
June 21, 2024, 9:32 am
Stirling-based nanomaterial producer iGii has secured a game-changing £8.8 million in new funding to propel its growth. Formerly known as Integrated Graphene, iGii has developed Gii™, a groundbreaking 3D foam crafted from carbon atoms. This innovative material embodies the sought-after physical properties of graphene, such as sensitivity, flexibility, and conductivity, without the daunting challenges of scaling up and mass application.
Gii is crafted using a proven low-energy and chemical-free process, resulting in minimal waste and making it a more cost-effective alternative to traditional sensing materials like gold. The University of Bath recently utilized Gii-Sens™ to support a cutting-edge battery-free sensor for monitoring lactic acid levels in athletes, paving the way for a user-friendly sensor accessible in remote locations without the need for electricity-powered equipment.
Jean-Christophe Granier, the CEO of iGii, expressed unwavering dedication to introducing their revolutionary Gii™ technology to various markets, particularly in the healthcare sector. The influx of funding will expedite ongoing customer projects and bolster their reel-to-reel manufacturing capabilities to distribute commercial quantities of Gii™ globally.
The funding round was spearheaded by a £4 million contribution from the Scottish National Investment Bank, with an additional £4.8 million from existing iGii shareholders Archangel Investors and Par Equity, both early investors in the company. Alastair McMillen, Associate Director of Sustainable Investment at the Bank, commended iGii's patented technology for its cutting-edge advancements in nanomaterials, aligning with the mission to foster innovation and enhance economic competitiveness.
Niki McKenzie, Joint Managing Director for Archangels, highlighted iGii as a prime example of a Scottish tech company with immense global potential, emphasizing their commitment to long-term growth. With the funding secured, iGii is poised to scale up the production of Gii-Sens™, a highly sensitive and accurate component crucial for point-of-care diagnostic sensors.
The demand for Gii-Sens™ is surging worldwide due to its ability to deliver precise, laboratory-level results for various illnesses and health indicators, including cancers, pathogens, and organ failure. iGii plans to intensify its research and development efforts to explore additional applications of Gii™, aiming to enhance performance in water and food quality sensors, agricultural sensors, and battery storage.
The collaboration with the University of Bath underscores iGii's commitment to innovation and pushing boundaries in nanomaterial technology. With the latest funding injection, iGii is poised to revolutionize the industry and solidify its position as a trailblazer in nanomaterial production.
Gii is crafted using a proven low-energy and chemical-free process, resulting in minimal waste and making it a more cost-effective alternative to traditional sensing materials like gold. The University of Bath recently utilized Gii-Sens™ to support a cutting-edge battery-free sensor for monitoring lactic acid levels in athletes, paving the way for a user-friendly sensor accessible in remote locations without the need for electricity-powered equipment.
Jean-Christophe Granier, the CEO of iGii, expressed unwavering dedication to introducing their revolutionary Gii™ technology to various markets, particularly in the healthcare sector. The influx of funding will expedite ongoing customer projects and bolster their reel-to-reel manufacturing capabilities to distribute commercial quantities of Gii™ globally.
The funding round was spearheaded by a £4 million contribution from the Scottish National Investment Bank, with an additional £4.8 million from existing iGii shareholders Archangel Investors and Par Equity, both early investors in the company. Alastair McMillen, Associate Director of Sustainable Investment at the Bank, commended iGii's patented technology for its cutting-edge advancements in nanomaterials, aligning with the mission to foster innovation and enhance economic competitiveness.
Niki McKenzie, Joint Managing Director for Archangels, highlighted iGii as a prime example of a Scottish tech company with immense global potential, emphasizing their commitment to long-term growth. With the funding secured, iGii is poised to scale up the production of Gii-Sens™, a highly sensitive and accurate component crucial for point-of-care diagnostic sensors.
The demand for Gii-Sens™ is surging worldwide due to its ability to deliver precise, laboratory-level results for various illnesses and health indicators, including cancers, pathogens, and organ failure. iGii plans to intensify its research and development efforts to explore additional applications of Gii™, aiming to enhance performance in water and food quality sensors, agricultural sensors, and battery storage.
The collaboration with the University of Bath underscores iGii's commitment to innovation and pushing boundaries in nanomaterial technology. With the latest funding injection, iGii is poised to revolutionize the industry and solidify its position as a trailblazer in nanomaterial production.